Breaks Categories: News

WednesdayOct 14, 2020 12:45 pm

NetworkNewsBreaks – Utopia VR Launches Iconic Zombie Experience as First in Series of VR-Themed Environments

Utopia VR today announced Zombie Land VR, an iconic zombie experience featuring a heart-pounding interactive, fully immersive virtual reality (“VR”) themed environment. Zombie Land VR is not a game or movie trailer, but an interactive, immersive virtual chat experience. Users can invite their friends and family to interact, or individuals can brave the experience alone, as participants walk through the foggy street at night, keeping watch for attacking zombies emerging from houses or behind parked cars. Zombie Land VR is the first in a series of VR-themed experiences to enter the entertainment and sports industry. Utopia VR, positioning to be…

Continue Reading

WednesdayOct 14, 2020 12:21 pm

NetworkNewsBreaks – WindESCo Inc. to Expand Customer Portfolio Across Europe

WindESCo, the leading provider of wind energy performance optimization solutions, today announced its expansion into the European wind energy market. According to the update, seasoned renewable energy sales executive Óscar Pérez will join the company as director of sales for Europe and oversee an office located in Seville, Spain. “With over 182 GW of wind capacity operating on the continent, the European wind energy market is the most mature and important market globally. Our analytics platform has found improvement potential on the projects we have completed in Europe so far,” WindESCo founder and CRO Mo Dua said in the news…

Continue Reading

WednesdayOct 14, 2020 12:01 pm

NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announcements Featured in “Emerging Markets Report”

Grey Cloak Tech's (OTC: GRCK) announcements of a planned name change and its new Clinical IMMUNE(tm) product designed to combat respiratory symptoms were top topics in this week’s issue of the “Emerging Markets Report”. The report noted that Grey Cloak Tech recently filed to change its name to Healthy Extracts Inc. to better align with its science-based, exclusive products and intellectual properties. The name change also reflects the company’s focus on its proprietary development of natural plant-based formulations and the sale and distribution of cardiovascular and neuro products. In addition, the company is releasing a new product — Clinical IMMUNE — which “Emerging…

Continue Reading

WednesdayOct 14, 2020 11:45 am

NetworkNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) to Sponsor 2020 Protecting New York Summit Virtual Event

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, has announced that it will sponsor this week’s 2020 Protecting New York Summit. The virtual event, scheduled for Thursday, Oct. 15, 2020, provides an opportunity for industry executives, public sector leaders and academics to share ideas about New York’s security strategy. The event agenda includes topics ranging community policing to keeping New Yorkers safe during the pandemic. In addition to its sponsorship, Wrap Technologies will have a participant in the summit. WRTC president Tom Smith is a featured panel member on a panel that will discuss New York’s public safety…

Continue Reading

WednesdayOct 14, 2020 11:12 am

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Releases BudCars Q3 Numbers, Report Highlights Sales Records for Burgeoning Business

Sugarmade (SGMD), a leading, multidivisional/multiproduct/multisector supply company, has shared a preannouncement of financial numbers for its BudCars Cannabis Delivery Service (“BudCars”). The announcement notes several new sales records. Highlights of the report include gross receipts reaching nearly $2 million, with more than 60% growth being reported in net sales, customer orders and gross profits on a quarter-to-quarter basis. BudCars has been consistently tracking ahead of expectations, the announcement states, with geographic expansion being a key component to continued growth and success. The company has plans in place to expand into the North San Francisco Bay Area as well as nearby…

Continue Reading

WednesdayOct 14, 2020 11:00 am

NetworkNewsBreaks – Oncocyte Corporation (NYSE American: OCX) Presents New DetermaRx(TM) Prospective Data at IASLC 2020 Conference

Oncocyte (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, is presenting new prospective data on DetermaRx(TM) at the IASLC 2020 North America Conference on Lung Cancer taking place on October 22. Gavitt Woodard, M.D., assistant professor, Yale School of Medicine, and lead author on the study is presenting the data at the event hosted by the International Association for the Study of Lung Cancer. Per the update, DetermaRx is a treatment stratification test that identifies stage I-IIA non-small cell lung cancer (“NSCLC”) patients at high-risk…

Continue Reading

WednesdayOct 14, 2020 10:44 am

NetworkNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Landmark Acquisition Featured in Stock2Me Podcast

SRAX (NASDAQ: SRAX), an innovative fintech solutions provider, was featured in the latest episode of The Stock2Me Podcast, an InvestorBrandNetwork (“IBN”) solution to provide specialized content distribution via widespread syndication channels. The episode features Christopher Miglino, founder and CEO of SRAX, and Chris Lahiji, president of LD Micro. During the program, the two executives discuss the recent acquisition of LD Micro, a leading data and event company serving the small and micro-cap space, by SRAX, a financial technology company that unlocks data and insights for publicly traded companies through its SaaS platform, Sequire. SRAX announced closing of the acquisition on…

Continue Reading

WednesdayOct 14, 2020 10:40 am

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Adds More Sites for Cystic Fibrosis Clinical Trials

AzurRx BioPharma (NASDAQ: AZRX) has activated additional clinical trial sites for its trial of MS1819 in cystic fibrosis. The company specializes in the development of nonsystemic, recombinant therapies for gastrointestinal diseases. The company has activated two additional trial sites in Turkey for its Phase 2 combination therapy trial of its lead drug candidate, MS1819. MS1819 is a recombinant lipase for the treatment of exocrine pancreatic insufficiency (“EPI”) in patients suffering from chronic pancreatitis and cystic fibrosis. Patient screening has already been initiated for the new trial sites, with topline data expected by Q2 2021. AzurRx had previously activated six clinical sites in Hungary,…

Continue Reading

WednesdayOct 14, 2020 10:12 am

NetworkNewsBreaks – Exro Technologies Inc. (TSX.V: XRO) (OTCQB: EXROF) Announces Granting of Incentive Stock Options

Exro Technologies (TSX.V: XRO) (OTCQB: EXROF), a leading technology company that has developed a new class of power electronics for electric motors and powertrains, has granted incentive stock options. The options are available to specific directors, officers, employees and consultants. Qualifying individuals can purchase a total of 2,618,000 shares in the capital of the company. The shares are available at $3.15 per share, with an expiration date of five years from the date of grant. All shares sold will be pursuant to the terms of the provided stock option plan. In addition, all options will be subject to vesting provisions,…

Continue Reading

WednesdayOct 14, 2020 10:08 am

NetworkNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Enters Strategic Alliance to Build ‘Smart Factories of the Future’

Sigma Labs (NASDAQ: SGLB), a leading developer of in-process quality assurance software for the commercial 3D metal printing industry, today announced its partnership with IN4.OS, a leader in advanced manufacturing. Under the collaboration, the partners will build “Smart Factories of the Future” to meet the demands of high technology sectors including defense, space, aerospace and life sciences. An IN4.OS US LLC concept, a Smart Factory of the Future is a cyber-physical system, location agnostic factory that has the ability to deliver flexible and scalable manufacturing capabilities. The design will integrate Sigma Labs' PrintRite3D(R) technology to ensure the highest level of…

Continue Reading